Abstract
It appears that the cytokines have significant therapeutic potential as an adjunct to established therapeutic regimens. It appears that, as single agents, they will have minimal therapeutic activity. However, in minimal residual disease settings or after debulking regimens by surgery, chemotherapy, or radiotherapy, significantly increased therapeutic activity can be expected by the addition of cytokines to treatment protocols.
Original language | English (US) |
---|---|
Pages (from-to) | 79-87 |
Number of pages | 9 |
Journal | Seminars in Thrombosis and Hemostasis |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - 1988 |
Externally published | Yes |
ASJC Scopus subject areas
- Hematology
- Cardiology and Cardiovascular Medicine